Comparison of Effectiveness Cost Therapy and Increasing Level of Haemoglobin, Ferritin in Pregnant Women with Anemia Whom Are Given Iron Tablet Everyday and Every Two Days
DOI:
https://doi.org/10.36408/mhjcm.v13i1.1338Keywords:
Anemia, Cost-effective therapy, Iron Supplementation, PregnancyAbstract
BACKGROUND: Anemia is common in pregnancy, with a prevalence of 48.9% in Indonesia (Riskesdas 2018). It increases the risk of impaired fetal growth, stunting, and intellectual disorders. Iron supplementation, as recommended by Permenkes No. 88/2014, is a key preventive strategy. Evidence such as Moretti et al. (2015), suggests that alternate-day supplementation improves absorption due to reduced hepcidin activity.
AIM: To evaluate the effectiveness of administering iron tablets every two days in terms of treatment cost, increases in hemoglobin (Hb) and ferritin levels, and incidence of gastrointestinal adverse effects.
METHODS: This was a true experimental study using a randomized pre–post test control group design. The control group received iron tablets daily for two months, while the intervention group received iron tablets every two days. The study was conducted at the Obstetrics and Gynecology Polyclinic of Kariadi Central General Hospital and Halmahera Primary Health Care over eight months (December 2023 – July 2024). Each group included 23 subjects. Body weight, hemoglobin, and ferritin were measured at baseline and after two months. Adverse effects and neonatal outcomes were also documented.
RESULTS: Baseline characteristics were normally distributed. The intervention group showed a significant increase in hemoglobin and ferritin levels, higher neonatal birth weight, and lower treatment cost and adverse effects compared to the control group (p < 0.05). Post-treatment differences between groups were 0.5 g/dL for hemoglobin and 17.2 ng/mL for ferritin.
CONCLUSION: Administering iron tablets every two days is effective in improving hemoglobin and ferritin levels in pregnant women with anemia and is also cost-effective with fewer adverse effects.
Downloads
References
1. World Health Organization. Global anaemia estimates, 2021 edition: anaemia in women and children. Geneva: WHO; 2021
2. Stevens GA, Finucane MM, De-Regil LM, et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in pregnant and non-pregnant women. Lancet Glob Health. 2013;1(1):e16–e25
3. Sunuwar DR, Singh DR, Chaudhary NK, et al. Prevalence and factors associated with anemia among women of reproductive age in South and Southeast Asian countries. PLoS One. 2020;15(8):e0236449
4. Badan Penelitian dan Pengembangan Kesehatan. Laporan Nasional RISKESDAS 2018. Jakarta: Kementerian Kesehatan RI; 2018.
5. James AH. Iron deficiency anemia in pregnancy. Obstet Gynecol. 2021 Oct;138(4):663–74.
6. Fisher AL, Nemeth E. Iron homeostasis during pregnancy. Am J Clin Nutr [Internet]. 2017; [cited 2025 Sep 11]. Available from: https://doi.org/10.3945/ajcn
7. World Health Organization. Guideline: Daily iron and folic acid supplementation in pregnant women [Internet]. Geneva: WHO; 2012 [cited 2025 Sep 11]. Available from: https://www.who.int
8. World Health Organization. Daily iron and folic acid supplementation in pregnant women: WHO Guideline 2012 [Internet]. 2012 [cited 2025 Sep 11]. Available from: https://peraturan.go.id
9. Bloor SR, Schutte R, Hobson AR. Oral iron supplementation—gastrointestinal side effects and the impact on the gut microbiota. Microbiol Res. 2021;12:491–502.
10. Banerjee A, Athalye S, Shingade P, Khargekar V, Mahajan N, Madkaikar M, et al. Efficacy of daily versus intermittent oral iron supplementation for prevention of anemia among pregnant women: a systematic review and meta-analysis. EClinicalMedicine. 2024 Aug;74:102221.
11. Breymann C, Auerbach M. Iron deficiency in gynecology and obstetrics: clinical implications and management [Internet]. 2019 [cited 2025 Sep 11]. Available from: https://www.myironfriend.com
12. Moretti D, Goede JS, Zeder C, Jiskra M, Chatzinakou V, Tjalsma H, et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood [Internet]. 2015;126(17):1981–9. Available from: https://clinicaltrials.gov
13. Koenig MD, Tussing-Humphreys L, Day J, Cadwell B, Nemeth E. Hepcidin and iron homeostasis during pregnancy. Nutrients. 2014;6(8):3062–83.
14. Garzon S, Cacciato PM, Certelli C, Salvaggio C, Magliarditi M, Rizzo G. Iron deficiency anemia in pregnancy: novel approaches for an old problem. Oman Med J. 2020 Sep;35(5):e166.
15. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 233: Clinical management guidelines for obstetrician–gynecologists. Obstet Gynecol. 2021 Aug;138(2):e55–64.
16. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin: Clinical management guidelines for obstetrician–gynecologists. Obstet Gynecol. 2008 Jul;112(1):201–7.
17. Desianti S, Dan K, Lestari K. Kajian farmakoekonomi yang mendasari pemilihan pengobatan di Indonesia: review artikel. Jurnal Farmasi Klinik Indonesia. 2018;7(2):140–7.
18. Methods for the Economic Evaluation of Health Care Programmes. Report.
19. Yajamín-Villamarín R. The Importance of a Methodological Manual for Economic Evaluations in Healthcare Decision-Making in Ecuador. Pharmacoecon Open. 2025 Sep 1;9(5):713–22. doi:10.1007/s41669-025-00585-z
20. Lam MC, et al. Daily versus alternate-day iron supplementation for treatment of iron deficiency anemia in pregnancy: a randomized controlled trial. Am J Perinatol. 2025. (PubMed)
21. Chu Lam MT, Khandakar B, Heon I, Hussain FN, Feldman KM, Kaplowitz E, et al. Daily vs alternate day iron for pregnant women with iron deficiency anemia: randomized controlled trial. Am J Obstet Gynecol. 2021 Feb;224(2 Suppl):S107.
22. von Siebenthal HK, Gessler S, Vallelian F, Steinwendner J, Kuenzi UM, Moretti D, et al. Alternate day versus consecutive day oral iron supplementation in iron-depleted women: a randomized double-blind placebo-controlled study. EClinicalMedicine. 2023 Nov;65:102291.
23. Manivannan P, et al. Daily versus alternate-day oral iron replacement in iron deficiency anemia: randomized controlled trial. Indian J Hematol Blood Transfus. 2024. (ResearchGate)
24. Mawla MJ, et al. Alternate-day versus daily iron supplementation in women with iron deficiency anemia: a clinical study. Iraqi Natl J Med. 2025. (Iqnjm)
25. Hake RR. Analyzing change/gain scores. Unpublished [Internet]. 1999 [cited 2025 Sep 11]. Available from: http://www.physics.indiana.edu/~sdi/AnalyzingChange-Gain.pdf
26. Karakoc G, Orgul G, Sahin D, Yucel A. Is every other day iron supplementation effective for the treatment of iron deficiency anemia in pregnancy? J Matern Fetal Neonatal Med. 2022;35(5):832–6.
27. Taylor P, Jain A, Hadi A, Iansavitchene A, Lazo-Langner A. Daily versus non-daily oral iron supplementation for the treatment of iron deficiency anemia: a systematic review and meta-analysis of randomized trials. Blood [Internet]. 2024 Nov 5;144(Suppl 1):5261. Available from: https://ashpublications.org/blood/article/144/Supplement%201/5261/526801
Additional Files
Published
How to Cite
Issue
Section
Citation Check
License
Copyright (c) 2026 Agung Pramartha Irawan, M. Besari Adi Pramono, Asih Wijayanti (Author)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyrights Notice
Copyrights:
Researchers publishing manuscrips at Medica Hospitalis: Journal of Clinical Medicine agree with regulations as follow:
Copyrights of each article belong to researchers, and it is likewise the patent rights
Researchers admit that Medica Hospitalia: Journal of Clinical Medicine has the right of first publication
Researchers may submit manuscripts separately, manage non exclusive distribution of published manuscripts into other versions (such as: being sent to researchers’ institutional repository, publication in the books, etc), admitting that manuscripts have been firstly published at Medica Hospitalia: Journal of Clinical Medicine
License:
Medica Hospitalia: Journal of Clinical Medicine is disseminated based on provisions of Creative Common Attribution-Share Alike 4.0 Internasional It allows individuals to duplicate and disseminate manuscripts in any formats, to alter, compose and make derivatives of manuscripts for any purpose. You are not allowed to use manuscripts for commercial purposes. You should properly acknowledge, reference links, and state that alterations have been made. You can do so in proper ways, but it does not hint that the licensors support you or your usage.
